Guru Ownership Trend
Guru Analysis for Stoke Therapeutics, Inc. (STOK)
Stoke Therapeutics, Inc. (STOK), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $4.31 M.
Top institutional holders include John Hussman and Cliff Asness.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $37.64 M net outflow during the quarter.
Recent activity highlights Jefferies Group who opened a new position.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Stoke Therapeutics, Inc. (STOK)
Major holders include John Hussman ($2.74 M), Cliff Asness ($1.51 M), Jefferies Group ($530,728). According to the latest reported data, 3 tracked investment managers collectively hold approximately 146,759 shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $37.64 M, with 3 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 0 managers trimmed their positions, while 2 fully exited STOK. The total reported sell value was $39.41 M.
Yes, 1 managers opened new positions in STOK, and 2 increased their existing holdings. The total reported buy value was $1.77 M.